MAXIPHARMA A/S: Financial statements 2012
CVR: 87375617
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,517,078 and a net result of DKK 740,393. Equity in the 2012 report amounted to DKK 2,298,478. The solvency ratio was 61.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,517,078
- Profit/Loss
- DKK 740,393
- Equity
- DKK 2,298,478
- Total Assets
- DKK 3,721,441
- Employees
- 2
Keep an eye on MAXIPHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of MAXIPHARMA A/S.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.